| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 28, 2026 | ±3.8% | -0.8% | over-priced |
| September 4, 2025 | ±2.5% | -4.8% | under-priced |
| May 29, 2025 | ±2.7% | -3.3% | under-priced |
| December 4, 2024 | ±2.3% | +11.0% | under-priced |
| August 29, 2024 | ±2.4% | -0.7% | over-priced |
| November 30, 2023 | ±1.4% | +9.4% | under-priced |
| August 31, 2023 | ±2.6% | +3.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $2.42 | $11.1B | $2.1B |
| Q4 FY2026 | — | $0 | $0 |
| Q2 FY2026 | $1.96 | $10.2B | $1.9B |
| Q1 FY2026 | $1.59 | $9.8B | $1.5B |
Salesforce, Inc. (CRM) reports in 143 days, with the next report estimated for November 3, 2026. Across the last 7 reports, options priced an average ±2.5% earnings move while the stock actually moved 4.7% on average — the market has tended to under-price CRM's earnings risk. Fundamentals into the print: EPS up 37.5% year-over-year, revenue up 11.4%. QuantLogix's live 5-factor engine currently reads CRM as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →